2009, ISBN: 9781607614159
[ED: Hardcover], [PU: Humana / Humana Press / Springer, Berlin], With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistical… More...
booklooker.de buecher.de GmbH & Co. KG Shipping costs:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) Details... |
2018, ISBN: 9781607614159
[ED: Buch], [PU: Humana Press], Neuware - Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severel… More...
booklooker.de |
ISBN: 9781607614159
Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severely limited by multidrug resistance, in that… More...
Springer.com Nr. 978-1-60761-415-9. Shipping costs:Worldwide free shipping, , plus shipping costs. (EUR 0.00) Details... |
ISBN: 9781607614159
Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severely limited by multidrug resistance, in that… More...
Springer.com Nr. 978-1-60761-415-9. Shipping costs:Worldwide free shipping, , DE. (EUR 0.00) Details... |
2009, ISBN: 1607614154
With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistically unrelated drugs, the efficacy of chemotherapeutic management o… More...
Weltbild.de Nr. 20783343. Shipping costs:, 2-5 Werktage, DE. (EUR 0.00) Details... |
2009, ISBN: 9781607614159
[ED: Hardcover], [PU: Humana / Humana Press / Springer, Berlin], With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistical… More...
2018, ISBN: 9781607614159
[ED: Buch], [PU: Humana Press], Neuware - Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severel… More...
ISBN: 9781607614159
Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severely limited by multidrug resistance, in that… More...
ISBN: 9781607614159
Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severely limited by multidrug resistance, in that… More...
2009, ISBN: 1607614154
With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistically unrelated drugs, the efficacy of chemotherapeutic management o… More...
Bibliographic data of the best matching book
Author: | |
Title: | |
ISBN: |
Details of the book - Multi-Drug Resistance in Cancer
EAN (ISBN-13): 9781607614159
ISBN (ISBN-10): 1607614154
Hardcover
Publishing year: 2010
Publisher: Humana Press
492 Pages
Weight: 1,267 kg
Language: eng/Englisch
Book in our database since 2009-10-17T18:26:40+01:00 (London)
Detail page last modified on 2024-03-13T09:41:56+00:00 (London)
ISBN/EAN: 9781607614159
ISBN - alternate spelling:
1-60761-415-4, 978-1-60761-415-9
Alternate spelling and related search-keywords:
Book author: zhou, jun, sierk
Book title: resistance, cancer
Information from Publisher
Author: Jun Zhou
Title: Methods in Molecular Biology; Multi-Drug Resistance in Cancer
Publisher: Humana; Humana Press
492 Pages
Publishing year: 2009-11-18
Totowa; NJ; US
Printed / Made in
Weight: 1,250 kg
Language: English
106,99 € (DE)
109,99 € (AT)
118,00 CHF (CH)
POD
XII, 492 p. 67 illus., 4 illus. in color.
BB; Oncology; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; ATP-binding; Cancer stem cells; Chemotherapy; Drug transporter function; P-glycoproteins; Regulation; Resistance reversal agents; tissue; antibacterial drug resistance; Cancer Research; Drug Resistance; Oncology; Cancer Biology; Medical Microbiology; Mikrobiologie und Virologie; BC; EA
1. Multidrug Resistance in Cancer Bruce C. Baguley 2. Multidrug Resistance in Oncology and Beyond: From Imaging of Drug Efflux Pumps to Cellular Drug Targets Wouter B. Nagengast, Thijs H. Oude Munnink, Eli C.F. Dijkers, Geke A.P. Hospers, Adrienne H. Brouwers, Carolien P. Schröder, Marjolijn Lub-de Hooge, and Elisabeth G.E. de Vries 3. Studying Drug Resistance Using Genetically Engineered Mouse Models for Breast Cancer Sven Rottenberg, Marina Pajic, and Jos Jonkers 4. Mechanisms of Multidrug Resistance in Cancer Jean-Pierre Gillet and Michael M. Gottesman 5. Molecular Mechanisms of Drug Resistance in Single-Step and Multi-Step Drug-Selected Cancer Cells Anna Maria Calcagno and Suresh V. Ambudkar 6. Pharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications Ingolf Cascorbi and Sierk Haenisch 7. Flow Cytometric Evaluation of Multidrug Resistance Proteins Adorjan Aszalos and Barbara J. Taylor 8. Targeted Chemotherapy in Drug Resistant Tumors and Noninvasive Imaging of P-Glycoprotein-Mediated Functional Transport in Cancer Jothilingam Sivapackiam, Seth T. Gammon, Scott E. Harpstrite, and Vijay Sharma 9. Epigenetic Regulation of Multidrug Resistance 1 Gene Expression: Profiling CpG Methylation Status Using Bisulphite Sequencing Emma K. Baker and Assam El-Osta 10. Expression and Function of P-Glycoprotein in Normal Tissues: Effect on Pharmacokinetics Frantisek Staud, Martina Ceckova, Stanislav Micuda, and Petr Pavek 11. Molecular Mechanism of ATP-Dependent Solute Transport by Multidrug Resistance-Associated Protein 1 Xiu-bao Chang 12. Impact of Breast Cancer Resistance Protein on Cancer Treatment Outcomes Douglas D. Ross and Takeo Nakanishi 13. Drug Ratio-Dependent Antagonism: A NewCategory of Multidrug Resistance and Strategies for Its Circumvention Troy O. Harasym, Barry D. Liboiron, and Lawrence D. Mayer 14. Reversing Agents for ATP-Binding Cassette Drug Transporters Chow H. Lee 15. Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors Helen M. Coley 16. Pharmacokinetic and Pharmacodynamic Implications of P-Glycoprotein Modulation Jeannie M. Padowski and Gary M. Pollack 17. Examination of CYP3A and P-Glycoprotein-Mediated Drug-Drug Interactions Using Animal Models Punit H. Marathe and A. David Rodrigues 18. Generating Inhibitors of P-Glycoprotein: Where to, Now? Emily Crowley, Christopher A. McDevitt, and Richard Callaghan 19. Immunosuppressors as Multidrug Resistance Reversal Agents Hamid Morjani and Claudie Madoulet 20. Overcoming Multidrug Resistance by RNA Interference Alexandra Stege, Andrea Krühn, and Hermann Lage 21. Circumventing Tumor Resistance to Chemotherapy by Nanotechnology Xing-Jie Liang, Chunying Chen, Yuliang Zhao, and Paul C. WangMore/other books that might be very similar to this book
Latest similar book:
9781607614166 Multi-Drug Resistance in Cancer (Jun Zhou)
< to archive...